These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12360428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 3. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL.
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB.
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [Abstract] [Full Text] [Related]

  • 10. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ.
    Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [Abstract] [Full Text] [Related]

  • 15. Natural history of hepatitis C and outcomes following liver transplantation.
    Rodriguez-Luna H, Vargas HE.
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):51-9. PubMed ID: 15719006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.
    Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, Bruguera M, Fuster J, Garcia-Valdecasas JC, Rimola A.
    Hepatology; 2004 Sep; 40(3):699-707. PubMed ID: 15349910
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.